Hepatocellular adenoma secondary prevention: Difference between revisions
Jump to navigation
Jump to search
(Mahshid) |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}}{{NM}} | {{CMG}}; {{AE}}{{NM}} | ||
==Overview== | ==Overview== | ||
An yearly followup with MRI or ultrasound may be scheduled for female patients until menopause. | |||
==Hepatocellular adenoma secondary prevention== | ==Hepatocellular adenoma secondary prevention== | ||
* An yearly followup with MRI or ultrasound may be scheduled for female patients until menopause, when the adenoma is < 5cm or regress to < 5cm after discontinuation of oral contracepative medications.<ref>{{Cite journal | |||
== | | author = [[Maarten G. Thomeer]], [[Mirelle Broker]], [[Joanne Verheij]], [[Michael Doukas]], [[Turkan Terkivatan]], [[Diederick Bijdevaate]], [[Robert A. De Man]], [[Adriaan Moelker]] & [[Jan N. IJzermans]] | ||
| title = Hepatocellular adenoma: when and how to treat? Update of current evidence | |||
| journal = [[Therapeutic advances in gastroenterology]] | |||
| volume = 9 | |||
| issue = 6 | |||
| pages = 898–912 | |||
| year = 2016 | |||
| month = November | |||
| doi = 10.1177/1756283X16663882 | |||
| pmid = 27803743 | |||
}}</ref> | |||
==References== | ==References== | ||
{{reflist|1}} | {{reflist|1}} | ||
Revision as of 14:33, 14 January 2019
|
Hepatocellular adenoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hepatocellular adenoma secondary prevention On the Web |
|
American Roentgen Ray Society Images of Hepatocellular adenoma secondary prevention |
|
Risk calculators and risk factors for Hepatocellular adenoma secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]
Overview
An yearly followup with MRI or ultrasound may be scheduled for female patients until menopause.
Hepatocellular adenoma secondary prevention
- An yearly followup with MRI or ultrasound may be scheduled for female patients until menopause, when the adenoma is < 5cm or regress to < 5cm after discontinuation of oral contracepative medications.[1]
References
- ↑ Maarten G. Thomeer, Mirelle Broker, Joanne Verheij, Michael Doukas, Turkan Terkivatan, Diederick Bijdevaate, Robert A. De Man, Adriaan Moelker & Jan N. IJzermans (2016). "Hepatocellular adenoma: when and how to treat? Update of current evidence". Therapeutic advances in gastroenterology. 9 (6): 898–912. doi:10.1177/1756283X16663882. PMID 27803743. Unknown parameter
|month=ignored (help)